Form 8-K - Current report:
SEC Accession No. 0001654954-23-013399
Filing Date
2023-10-26
Accepted
2023-10-26 08:01:02
Documents
14
Period of Report
2023-10-25
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K edsa_8k.htm   iXBRL 8-K 22895
  Complete submission text file 0001654954-23-013399.txt   141830

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA edsa-20231025.xsd EX-101.SCH 5741
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20231025_lab.xml EX-101.LAB 14059
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20231025_cal.xml EX-101.CAL 912
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20231025_pre.xml EX-101.PRE 8894
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20231025_def.xml EX-101.DEF 2113
8 EXTRACTED XBRL INSTANCE DOCUMENT edsa_8k_htm.xml XML 3425
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 231347538
SIC: 2834 Pharmaceutical Preparations